269 related articles for article (PubMed ID: 23399651)
21. The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.
Wieczorek K; Braczkowski RS; Skrzypek M; Stryjewski PJ; Kuczaj A; Al-Srory G
J Biol Regul Homeost Agents; 2015; 29(1):207-11. PubMed ID: 25864760
[TBL] [Abstract][Full Text] [Related]
22. Effects of age and sex hormones on transition and peripheral zone volumes of prostate and benign prostatic hyperplasia in twins.
Meikle AW; Stephenson RA; Lewis CM; Middleton RG
J Clin Endocrinol Metab; 1997 Feb; 82(2):571-5. PubMed ID: 9024256
[TBL] [Abstract][Full Text] [Related]
23. Relationship of serum sex-steroid hormones and prostate volume in African American men.
Joseph MA; Wei JT; Harlow SD; Cooney KA; Dunn RL; Jaffe CA; Montie JE; Schottenfeld D
Prostate; 2002 Dec; 53(4):322-9. PubMed ID: 12430143
[TBL] [Abstract][Full Text] [Related]
24. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
25. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
Chen MJ; Yang WS; Yang JH; Hsiao CK; Yang YS; Ho HN
Hum Reprod; 2006 Sep; 21(9):2266-71. PubMed ID: 16757555
[TBL] [Abstract][Full Text] [Related]
26. Association between serum 25-hydroxyvitamin D and serum sex steroid hormones among men in NHANES.
Anic GM; Albanes D; Rohrmann S; Kanarek N; Nelson WG; Bradwin G; Rifai N; McGlynn KA; Platz EA; Mondul AM
Clin Endocrinol (Oxf); 2016 Aug; 85(2):258-66. PubMed ID: 26991691
[TBL] [Abstract][Full Text] [Related]
27. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
28. Insulin and free oestradiol are independent risk factors for benign prostatic hyperplasia.
Hammarsten J; Damber JE; Karlsson M; Knutson T; Ljunggren O; Ohlsson C; Peeker R; Smith U; Mellström D
Prostate Cancer Prostatic Dis; 2009; 12(2):160-5. PubMed ID: 18825163
[TBL] [Abstract][Full Text] [Related]
29. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.
Yasui T; Tomita J; Miyatani Y; Yamada M; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
Clin Chim Acta; 2007; 386(1-2):69-75. PubMed ID: 17825805
[TBL] [Abstract][Full Text] [Related]
30. Sex hormone-binding globulin and lipid profile in pubertal children.
Garcés C; Oya Id; Lasunción MA; López-Simón L; Cano B; de Oya M
Metabolism; 2010 Feb; 59(2):166-71. PubMed ID: 19765778
[TBL] [Abstract][Full Text] [Related]
31. Investigation of the potential association of vitamin D binding protein with lipoproteins.
Speeckaert MM; Taes YE; De Buyzere ML; Christophe AB; Kaufman JM; Delanghe JR
Ann Clin Biochem; 2010 Mar; 47(Pt 2):143-50. PubMed ID: 20144976
[TBL] [Abstract][Full Text] [Related]
32. Low serum sex hormone-binding globulin: marker of inflammation?
Liao CH; Li HY; Yu HJ; Chiang HS; Lin MS; Hua CH; Ma WY
Clin Chim Acta; 2012 Apr; 413(7-8):803-7. PubMed ID: 22293276
[TBL] [Abstract][Full Text] [Related]
33. [Relation between benign prostatic hyperplasia and obesity and estrogen].
Matsuda T; Abe H; Suda K
Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594
[TBL] [Abstract][Full Text] [Related]
34. Relation between androgens and cardiovascular risk factors in a young population.
Gannagé-Yared MH; Chedid R; Abs L
Clin Endocrinol (Oxf); 2011 Jun; 74(6):720-5. PubMed ID: 21521259
[TBL] [Abstract][Full Text] [Related]
35. Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population.
Gannagé-Yared MH; Fares F; Semaan M; Khalife S; Jambart S
Clin Endocrinol (Oxf); 2006 Jun; 64(6):652-8. PubMed ID: 16712667
[TBL] [Abstract][Full Text] [Related]
36. [Studies on sex hormone-binding globulin in the prostate].
Jiang H; Chen Z
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):443-4, 448. PubMed ID: 15267211
[TBL] [Abstract][Full Text] [Related]
37. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study.
Parsons JK; Palazzi-Churas K; Bergstrom J; Barrett-Connor E
J Urol; 2010 Sep; 184(3):1040-4. PubMed ID: 20643424
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of lipids, total antioxidants, and trace metals in benign prostate hyperplasia and prostate cancer.
Adedapo KS; Arinola OG; Shittu OB; Kareem OI; Okolo CA; Nwobi LN
Niger J Clin Pract; 2012; 15(3):293-7. PubMed ID: 22960963
[TBL] [Abstract][Full Text] [Related]
39. Association between serum alpha-tocopherol and serum androgens and estrogens in older men.
Hartman TJ; Dorgan JF; Virtamo J; Tangrea JA; Taylor PR; Albanes D
Nutr Cancer; 1999; 35(1):10-5. PubMed ID: 10624701
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D and benign prostatic hyperplasia -- a review.
Espinosa G; Esposito R; Kazzazi A; Djavan B
Can J Urol; 2013 Aug; 20(4):6820-5. PubMed ID: 23930605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
